AstraZeneca second quarter profit beats expectations

The London-listed company, which reports its results in U.S. dollars, posted an adjusted profit of $2.15 per share on sales of about $11.42 billion. Analysts were expecting $1.98 per share on sales of about $10.97 billion, according to company-compiled consensus estimates.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/fmQBtAu
via